Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
BIIB
Biogen Inc.
Biogen's LEQEMBI is an Alzheimer's disease therapeutic, a direct product the company manufactures and sells.
|
$26.02B |
$177.33
+0.74%
|
|
UTHR
United Therapeutics Corporation
UTHR's core PAH/CV therapy portfolio centers on prostacyclin cardiovascular drugs, including Tyvaso, Remodulin, Orenitram, and Ralinepag (where applicable).
|
$25.33B |
$588.10
+1.31%
|
|
DXCM
DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
|
$24.95B |
$63.99
+4.51%
|
|
BNTX
BioNTech SE
The company is pivoting toward oncology with immunotherapies, making Biotech - Oncology a core product/business focus.
|
$24.75B |
$102.82
+0.69%
|
|
HUM
Humana Inc.
Humana's core revenue and offerings are health insurance products and related services for individuals, employers, and government programs.
|
$24.67B |
$205.19
+2.21%
|
|
CHD
Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
|
$23.26B |
$96.84
+2.43%
|
|
VLTO
Veralto Corporation
Veralto may offer laboratory testing and advisory services around water quality testing and compliance.
|
$22.59B |
$90.95
+0.46%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$22.44B |
$270.80
+1.67%
|
|
STE
STERIS plc
STERIS manufactures surgical equipment, including sterilizers and endoscope-related devices used in operating rooms and infection prevention.
|
$22.16B |
$225.86
+2.68%
|
|
DGX
Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
|
$21.69B |
$195.00
+1.85%
|
|
BWXT
BWX Technologies, Inc.
Radiopharmaceuticals for nuclear medicine imaging and diagnostics.
|
$21.56B |
$235.64
+2.10%
|
|
MRNA
Moderna, Inc.
Direct vaccines products (Spikevax and pipeline vaccines) are Moderna's core revenue drivers and product line.
|
$20.99B |
$53.73
-1.73%
|
|
ROIV
Roivant Sciences Ltd.
Immunovant's FcRn-targeting therapies (e.g., IMVT-1402, batoclimab) are monoclonal antibody therapeutics.
|
$20.75B |
$29.80
+2.11%
|
|
ILMN
Illumina, Inc.
Sequencing instruments and related medical device equipment are Illumina's core manufactured products sold to researchers and clinical labs.
|
$20.55B |
$134.41
+1.27%
|
|
EXAS
Exact Sciences Corporation
Oncotype DX is a genomic assay used as a companion diagnostic in oncology, and the company discusses companion diagnostic capabilities and leadership in Precision Oncology.
|
$19.88B |
$104.93
+0.02%
|
|
SNA
Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
|
$19.78B |
$380.37
+3.68%
|
|
WST
West Pharmaceutical Services, Inc.
West generates revenue from contract manufacturing services, moving towards higher-margin opportunities.
|
$19.69B |
$273.73
+1.45%
|
|
WAT
Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
|
$19.51B |
$327.92
+2.78%
|
|
IFF
International Flavors & Fragrances Inc.
DEB and enzyme-based biotechnologies are core to IFF's Health & Biosciences innovation and product offerings.
|
$19.43B |
$75.87
+5.29%
|
|
INCY
Incyte Corporation
Incyte's business is centered on oncology-focused therapeutics, including Monjuvi and a broad cancer pipeline.
|
$19.20B |
$97.81
+2.61%
|
|
ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
|
$18.78B |
$94.77
-0.01%
|
|
CNC
Centene Corporation
Centene's core business is providing health insurance (Medicaid/Medicare and Marketplace) via managed care programs, making Health Insurance its direct product/service.
|
$18.76B |
$38.16
-2.15%
|
|
SMMT
Summit Therapeutics Inc.
Ivonescimab is a PD-1/VEGF bispecific antibody, placing Summit in the Bispecific Antibodies investable theme.
|
$18.72B |
$25.14
+2.97%
|
|
ULS
UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
|
$18.43B |
$91.70
+2.34%
|
|
GMAB
Genmab A/S
Genmab is a biotechnology company focused on oncology therapeutics, fitting Biotech - Oncology.
|
$18.33B |
$28.54
+0.85%
|
|
THC
Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
|
$17.28B |
$196.61
+2.40%
|
|
HOLX
Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
|
$16.94B |
$76.03
+0.03%
|
|
VTRS
Viatris Inc.
Viatris is a large-scale producer of generic medicines and biosimilars, core to its business.
|
$16.91B |
$14.68
+4.75%
|
Showing page 4 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
